Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
Claudia P. Arevalo, Marcus J. Bolton, Valerie Le Sage, et al.
Science (2022) Vol. 378, Iss. 6622, pp. 899-904
Open Access | Times Cited: 221

Showing 1-25 of 221 citing articles:

mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 110
Nanotechnology-based mRNA vaccines
Shuying Chen, Xiangang Huang, Yonger Xue, et al.
Nature Reviews Methods Primers (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 72
mRNA-based therapeutics: looking beyond COVID-19 vaccines
Hamideh Parhiz, Elena N. Atochina‐Vasserman, Drew Weissman
The Lancet (2024) Vol. 403, Iss. 10432, pp. 1192-1204
Closed Access | Times Cited: 71
Clinical delivery of circular RNA: Lessons learned from RNA drug development
Tiana L. Young, Kevin Chang Wang, Andrew Varley, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114826-114826
Closed Access | Times Cited: 69
mRNA vaccines as an armor to combat the infectious diseases
Priyanka Choudhary, Hitesh Chopra, Om Prakash Choudhary
Travel Medicine and Infectious Disease (2023) Vol. 52, pp. 102550-102550
Open Access | Times Cited: 67
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 66
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
K. Swetha, Niranjan G. Kotla, Lakshmi Tunki, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 658-658
Open Access | Times Cited: 63
US public investment in development of mRNA covid-19 vaccines: retrospective cohort study
Hussain S. Lalani, Sarosh Nagar, Ameet Sarpatwari, et al.
BMJ (2023), pp. e073747-e073747
Open Access | Times Cited: 55
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Co-evolution of immunity and seasonal influenza viruses
Alvin X. Han, Simon P. J. de Jong, Colin A. Russell
Nature Reviews Microbiology (2023) Vol. 21, Iss. 12, pp. 805-817
Closed Access | Times Cited: 50
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 49
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
Jiawei Zeng, Yao Li, Linrui Jiang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus
Colleen Furey, Gabrielle Scher, Naiqing Ye, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 31
Branched chemically modified poly(A) tails enhance the translation capacity of mRNA
Hongyu Chen, Dangliang Liu, Jianting Guo, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 29
Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives
Farah Rehan, Mingjie Zhang, Jun Fang, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2073-2073
Open Access | Times Cited: 23
Fluorinated Lipid Nanoparticles for Enhancing mRNA Delivery Efficiency
Huipeng Zhang, Chaoyang Meng, Xuewen Yi, et al.
ACS Nano (2024) Vol. 18, Iss. 11, pp. 7825-7836
Closed Access | Times Cited: 22
A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 20
Zoonotic infections by avian influenza virus: changing global epidemiology, investigation, and control
Mei Kang, Lifang Wang, Bowen Sun, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 8, pp. e522-e531
Closed Access | Times Cited: 18
Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines
Colin A. Russell, Ron A. M. Fouchier, Parinaz Ghaswalla, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 16
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 16
Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines
Pan Huang, Lujia Sun, Jinhao Li, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Advanced delivery systems for peptide antibiotics
Angela Cesaro, Shuang‐Zhe Lin, Norbert Pardi, et al.
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114733-114733
Open Access | Times Cited: 40
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
Laura Matarazzo, Paulo Bettencourt
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Development and applications of mRNA treatment based on lipid nanoparticles
Zhe Wang, Wanting Ma, Xingxing Fu, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108130-108130
Closed Access | Times Cited: 32
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
Taishi Kimura, Joseph M. Leal, Adrian Simpson, et al.
Molecular Therapy (2023) Vol. 31, Iss. 8, pp. 2360-2375
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top